PTEN regulation of the p110 isoforms switch has been observed and reported in multiple types of cancer, and in prostate cancer, p110β activation has been shown to primarily mediate PTEN-loss driven tumorigenesis [55,56,57,58]. The gene discussed is PTEN; the disease is prostate cancer.